Book Building
₹ 1,500.00 cr
₹ 0
-
₹ -
MumbaiNSE
-
-
-
Initial public offering of up to [*] equity shares of face value of Rs. 1/- each (Equity Shares) of Sahajanand Medical Technologies Limited (The Company or the Issuer) for cash at a price of Rs. [*] per equity share including a share premium of Rs. [*] per equity share (The Offer Price) aggregating up to Rs. 1500.00 crores (The Offer). The offer comprises of a fresh issue of up to [*] equity shares by the company aggregating up to Rs. 410.33 crores(The Fresh Issue) and an offer for sale of upto [*] equity shares (The Offered Shares) aggregating up to Rs. 1089.67 crores (The Offer for Sale), comprising of up to [*] equity shares aggregating to Rs. 100 crores by Dhirajkumar S.Vasoya, up to [*] equity shares aggregating up to Rs. 33.75 crores by Shree Hari Trust (acting through its trustee),up to [*] equity shares aggregating up to Rs. 635.56 crores by Samara Capital Markets Holding Limited and up to [*] equity shares aggregating up to Rs. 320.36 crores by Nhpea Sparkle Holding b.v.(collectively ,The Selling Shareholders),(The Offer for sale,and together with the fresh issue,the Offer). The offer will constitute [*] % of the post-offer paid-up equity share capital of the company.The company, in consultation with the brlms, is considering a pre-ipo placement of such number of equity shares for cash consideration aggregating up to Rs. 185 crres, at its discretion, (pre-ipo placement). the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the book running lead managers. if the pre-ipo placement is completed, the fresh issue size will be reduced to the extent of such pre-ipo placement, subject to compliance with the minimum offersize equirements prescribed under regulation 19(2)(b) of the scrr.The face value of the equity share is Rs. 1 the offer price is [*] times the face value of the equity shares.The price band and the minimum bid lot size will be decided by the company.
Repayment/prepayment of certain indebtedness availed by the company and subsidiaries. Funding the working capital requirementes of the company indirect foreign subsidiary Vascular Innovations. General corporate purposes.
Sahajanand Medical Technologies Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - investors@smt.in
Website - www.smtpl.com